Published in J Am Acad Child Adolesc Psychiatry on February 01, 2001
Rhodiola Rosea in Adults With Attention Deficit/Hyperactivity Disorder | NCT02737020
Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA (2010) 3.28
European clinical guidelines for hyperkinetic disorder -- first upgrade. Eur Child Adolesc Psychiatry (2004) 3.22
State of the science on psychosocial interventions for ethnic minorities. Annu Rev Clin Psychol (2005) 3.03
Evidence-based psychosocial treatments for ethnic minority youth. J Clin Child Adolesc Psychol (2008) 2.62
Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): an empirical analysis in the MTA study. J Abnorm Child Psychol (2000) 2.36
Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. J Am Acad Child Adolesc Psychiatry (2013) 2.30
Hippocampus and amygdala morphology in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry (2006) 2.06
Parent and teacher SNAP-IV ratings of attention deficit hyperactivity disorder symptoms: psychometric properties and normative ratings from a school district sample. Assessment (2008) 2.05
National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007. J Am Acad Child Adolesc Psychiatry (2010) 1.84
Family processes and treatment outcome in the MTA: negative/ineffective parenting practices in relation to multimodal treatment. J Abnorm Child Psychol (2000) 1.76
Enhancements to the behavioral parent training paradigm for families of children with ADHD: review and future directions. Clin Child Fam Psychol Rev (2004) 1.75
A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med (2012) 1.67
A family-school intervention for children with ADHD: results of a randomized clinical trial. J Consult Clin Psychol (2012) 1.64
Screening for the attention deficit hyperactivity disorder phenotype using the strength and difficulties questionnaire. Eur Child Adolesc Psychiatry (2011) 1.60
Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression. J Am Acad Child Adolesc Psychiatry (2014) 1.58
Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. J Am Acad Child Adolesc Psychiatry (2009) 1.55
Understanding decision-making deficits in neurological conditions: insights from models of natural action selection. Philos Trans R Soc Lond B Biol Sci (2007) 1.35
Parent-reported homework problems in the MTA study: evidence for sustained improvement with behavioral treatment. J Clin Child Adolesc Psychol (2010) 1.31
Predictors of adolescent functioning in girls with attention deficit hyperactivity disorder (ADHD): the role of childhood ADHD, conduct problems, and peer status. J Clin Child Adolesc Psychol (2006) 1.25
The efficacy and tolerability of methylphenidate and behavior modification in children with attention-deficit/hyperactivity disorder and severe mood dysregulation. J Child Adolesc Psychopharmacol (2008) 1.23
A randomized trial of two promising computer-based interventions for students with attention difficulties. J Abnorm Child Psychol (2010) 1.20
The influences of environmental enrichment, cognitive enhancement, and physical exercise on brain development: can we alter the developmental trajectory of ADHD? Neurosci Biobehav Rev (2010) 1.20
What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit/hyperactivity disorder? J Am Acad Child Adolesc Psychiatry (2013) 1.15
Stimulant treatment in children with attention-deficit/hyperactivity disorder moderates adolescent academic outcome. J Child Adolesc Psychopharmacol (2008) 1.15
Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2009) 1.15
An observational study of once-daily modified-release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safety. Eur Child Adolesc Psychiatry (2011) 1.11
Outcome measures for clinical trials in fragile X syndrome. J Dev Behav Pediatr (2013) 1.10
Cogmed Working Memory Training for youth with ADHD: a closer examination of efficacy utilizing evidence-based criteria. J Clin Child Adolesc Psychol (2013) 1.10
The treatment of severe child aggression (TOSCA) study: Design challenges. Child Adolesc Psychiatry Ment Health (2011) 1.05
Adolescents with childhood ADHD and comorbid disruptive behavior disorders: aggression, anger, and hostility. Child Psychiatry Hum Dev (2008) 1.04
Parent cognitions as predictors of child treatment response in attention-deficit/hyperactivity disorder. J Abnorm Child Psychol (2000) 1.04
Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading procedures. J Abnorm Child Psychol (2004) 1.03
Peer functioning in children with ADHD. Ambul Pediatr (2007) 1.03
Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysis. Child Adolesc Psychiatry Ment Health (2011) 1.01
The neurobiological basis of ADHD. Ital J Pediatr (2010) 0.99
An open study of adjunct OROS-methylphenidate in children and adolescents who are atomoxetine partial responders: I. Effectiveness. J Child Adolesc Psychopharmacol (2009) 0.98
EEG neurofeedback for ADHD: double-blind sham-controlled randomized pilot feasibility trial. J Atten Disord (2012) 0.97
French version of the strengths and weaknesses of ADHD symptoms and normal behaviors (SWAN-F) questionnaire. J Can Acad Child Adolesc Psychiatry (2007) 0.96
Treatment for ADHD: is more complex treatment cost-effective for more complex cases? Health Serv Res (2007) 0.96
Toward mapping daily challenges of living with ADHD: maternal and child perspectives using electronic diaries. J Abnorm Child Psychol (2006) 0.95
An Analysis of Teacher Investment in the Context of a Family-School Intervention for Children with ADHD. School Ment Health (2009) 0.95
The spectrum of the behavioral phenotype in boys and adolescents 47,XXY (Klinefelter syndrome). Pediatr Endocrinol Rev (2010) 0.95
Genotype and neuropsychological response inhibition as resilience promoters for attention-deficit/hyperactivity disorder, oppositional defiant disorder, and conduct disorder under conditions of psychosocial adversity. Dev Psychopathol (2007) 0.93
Parent attendance and homework adherence predict response to a family-school intervention for children with ADHD. J Clin Child Adolesc Psychol (2013) 0.93
Impaired neurocognitive functions affect social learning processes in oppositional defiant disorder and conduct disorder: implications for interventions. Clin Child Fam Psychol Rev (2012) 0.93
Self-esteem evaluation in children and adolescents suffering from ADHD. Clin Pract Epidemiol Ment Health (2013) 0.93
Systematic review of pharmacotherapy of disruptive behavior disorders in children and adolescents. Psychopharmacology (Berl) (2006) 0.92
Adrenergic alpha2A receptor gene and response to methylphenidate in attention-deficit/hyperactivity disorder-predominantly inattentive type. J Neural Transm (Vienna) (2008) 0.91
Effectiveness of an adaptive multimodal treatment in children with Attention-Deficit Hyperactivity Disorder -- global outcome. Eur Child Adolesc Psychiatry (2004) 0.90
Delay and inhibition as early predictors of ADHD symptoms in third grade. J Abnorm Child Psychol (2009) 0.90
Differentiating attention-deficit/hyperactivity disorder inattentive and combined types: a (1)H-magnetic resonance spectroscopy study of fronto-striato-thalamic regions. J Neural Transm (Vienna) (2009) 0.90
Prevalence of the ADHD phenotype in 7- to 9-year-old children: effects of informant, gender and non-participation. Soc Psychiatry Psychiatr Epidemiol (2011) 0.90
An RCT into the effects of neurofeedback on neurocognitive functioning compared to stimulant medication and physical activity in children with ADHD. Eur Child Adolesc Psychiatry (2016) 0.90
CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles. J Med Genet (2014) 0.90
Teacher reports of hypoactivity symptoms reflect slow cognitive processing speed in primary school children. Eur Child Adolesc Psychiatry (2010) 0.89
Relationship between atomoxetine plasma concentration, treatment response and tolerability in attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. Atten Defic Hyperact Disord (2009) 0.89
Clinical and molecular implications of mosaicism in FMR1 full mutations. Front Genet (2014) 0.89
A randomized controlled trial of CBT therapy for adults with ADHD with and without medication. BMC Psychiatry (2012) 0.89
Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder. Arch Dis Child (2005) 0.88
Zinc for attention-deficit/hyperactivity disorder: placebo-controlled double-blind pilot trial alone and combined with amphetamine. J Child Adolesc Psychopharmacol (2011) 0.88
Using long-acting stimulants: does it change ADHD treatment outcome? Can Child Adolesc Psychiatr Rev (2005) 0.87
The attention network test: a characteristic pattern of deficits in children with ADHD. Behav Brain Funct (2008) 0.87
Overlap Between Autism Spectrum Disorders and Attention Deficit Hyperactivity Disorder: Searching for Distinctive/Common Clinical Features. Autism Res (2015) 0.86
Treatment planning for children with attention-deficit/hyperactivity disorder: treatment utilization and family preferences. Patient Prefer Adherence (2011) 0.86
Heart rate and treatment effect in children with disruptive behavior disorders. Child Psychiatry Hum Dev (2007) 0.86
Caregivers' distress: youth with attention-deficit/hyperactivity disorder and comorbid disorders assessed via telemental health. J Child Adolesc Psychopharmacol (2013) 0.85
Neurofeedback in children with attention-deficit/hyperactivity disorder (ADHD)--a controlled multicenter study of a non-pharmacological treatment approach. BMC Pediatr (2014) 0.85
A randomized trial examining the effects of aerobic physical activity on attention-deficit/hyperactivity disorder symptoms in young children. J Abnorm Child Psychol (2015) 0.85
Iron, Magnesium, Vitamin D, and Zinc Deficiencies in Children Presenting with Symptoms of Attention-Deficit/Hyperactivity Disorder. Children (Basel) (2014) 0.84
Adolescent emotionality and effortful control: Core latent constructs and links to psychopathology and functioning. J Pers Soc Psychol (2015) 0.83
Effect of treatment modality on long-term outcomes in attention-deficit/hyperactivity disorder: a systematic review. PLoS One (2015) 0.83
Instability in teacher ratings of children's inattentive symptoms: implications for the assessment of ADHD. J Dev Behav Pediatr (2010) 0.83
Oppositional defiant disorder-gender differences in co-occurring symptoms of mental health problems in a general population of children. J Abnorm Child Psychol (2011) 0.83
Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity. J Child Adolesc Psychopharmacol (2010) 0.83
Clinical symptoms and performance on the Continuous Performance Test in children with attention deficit hyperactivity disorder between subtypes: a natural follow-up study for 6 months. BMC Psychiatry (2011) 0.83
Influence of assessment instrument on ADHD diagnosis. Eur Child Adolesc Psychiatry (2013) 0.82
Slow cortical potential neurofeedback and self-management training in outpatient care for children with ADHD: study protocol and first preliminary results of a randomized controlled trial. Front Hum Neurosci (2014) 0.82
Physical exercise and catecholamine reuptake inhibitors affect orienting behavior and social interaction in a rat model of attention-deficit/hyperactivity disorder. Behav Neurosci (2012) 0.82
Emotional/behavioral problems and functional impairment in clinic- and community-based children with attention-deficit/hyperactivity disorder in Taiwan. J Abnorm Child Psychol (2010) 0.82
Long-acting medications for the hyperkinetic disorders. A note on cost-effectiveness. Eur Child Adolesc Psychiatry (2007) 0.82
Parents' reactions to youths' hyperactivity, impulsivity, and attention problems. J Abnorm Child Psychol (2011) 0.82
Genomic studies in fragile X premutation carriers. J Neurodev Disord (2014) 0.82
The Role of Parental ADHD in Sustaining the Effects of a Family-School Intervention for ADHD. J Clin Child Adolesc Psychol (2014) 0.82
Improving outcomes for youth with ADHD: a conceptual framework for combined neurocognitive and skill-based treatment approaches. Clin Child Fam Psychol Rev (2014) 0.81
Psychometric properties of teacher SKAMP ratings from a community sample. Assessment (2008) 0.81
Compensatory brain activation in children with attention deficit/hyperactivity disorder during a simplified Go/No-go task. J Neural Transm (Vienna) (2011) 0.81
Individual and combined effects of physical exercise and methylphenidate on orienting behavior and social interaction in spontaneously hypertensive rats. Behav Neurosci (2014) 0.81
Treatment Sequencing for Childhood ADHD: A Multiple-Randomization Study of Adaptive Medication and Behavioral Interventions. J Clin Child Adolesc Psychol (2016) 0.81
The severely impaired do profit most: short-term and long-term predictors of therapeutic change for a parent management training under routine care conditions for children with externalizing problem behavior. Eur Child Adolesc Psychiatry (2009) 0.80
Anthroposophic therapy for attention deficit hyperactivity: a two-year prospective study in outpatients. Int J Gen Med (2010) 0.80
The challenges of implementing ADHD clinical guidelines and research best evidence in routine clinical care settings: Delphi survey and mixed-methods study. BJPsych Open (2016) 0.80
Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescents. Pharmacoeconomics (2012) 0.80
The Tourette International Collaborative Genetics (TIC Genetics) study, finding the genes causing Tourette syndrome: objectives and methods. Eur Child Adolesc Psychiatry (2014) 0.80
Temperament factors and dimensional, latent bifactor models of child psychopathology: Transdiagnostic and specific associations in two youth samples. Psychiatry Res (2017) 0.80
The Link between Peer Relations, Prosocial Behavior, and ODD/ADHD Symptoms in 7-9-Year-Old Children. Psychiatry J (2012) 0.80
Development of a Family-School Intervention for Young Children With Attention Deficit Hyperactivity Disorder. School Psych Rev (2012) 0.80
Prevalence and diagnostic stability of ADHD and ODD in Turkish children: a 4-year longitudinal study. Child Adolesc Psychiatry Ment Health (2013) 0.80
Switching from methylphenidate immediate release to MPH-SODAS in attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry (2008) 0.79
Comparative Cost Analysis of Sequential, Adaptive, Behavioral, Pharmacological, and Combined Treatments for Childhood ADHD. J Clin Child Adolesc Psychol (2016) 0.79
Adrenergic neurotransmitter system transporter and receptor genes associated with atomoxetine response in attention-deficit hyperactivity disorder children. J Neural Transm (Vienna) (2012) 0.79
The sequence of the human genome. Science (2001) 101.55
Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest (2001) 23.21
Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA (1989) 11.97
Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry (1994) 11.85
Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet (1989) 10.39
The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity. J Am Acad Child Adolesc Psychiatry (1997) 8.76
The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study. J Am Acad Child Adolesc Psychiatry (1996) 8.16
The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. Arch Gen Psychiatry (1992) 7.36
Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry (2001) 7.30
The assessment of affective disorders in children and adolescents by semistructured interview. Test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children, present episode version. Arch Gen Psychiatry (1985) 6.91
Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet (1998) 5.34
Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J Virol (1999) 5.21
Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA (1998) 5.09
Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset. Arch Gen Psychiatry (1993) 4.98
A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet (1999) 4.96
A simple colorimetric method for determination of protein. Anal Biochem (1969) 4.87
Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations. Obes Rev (2006) 4.74
A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetologia (2008) 4.62
Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst (2000) 4.50
Potassium-dependant mutants of Escherichia coli K-12. J Bacteriol (1970) 4.44
Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study. JAMA (1995) 4.40
Cell cycle dynamics of an M-phase-specific cytoplasmic factor in Xenopus laevis oocytes and eggs. J Cell Biol (1984) 4.20
Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA (1996) 4.13
Reducing HIV sexual risk behaviors among runaway adolescents. JAMA (1991) 4.10
Coming to terms with the terms of risk. Arch Gen Psychiatry (1997) 3.98
A teacher rating scale for use in drug studies with children. Am J Psychiatry (1969) 3.89
Epidemiology of depressive mood in adolescents: an empirical study. Arch Gen Psychiatry (1982) 3.81
The effect of cold narcosis on reflex action in warm-blooded animals. J Physiol (1905) 3.73
Actin-dependent propulsion of endosomes and lysosomes by recruitment of N-WASP. J Cell Biol (2000) 3.71
Genome of Geobacter sulfurreducens: metal reduction in subsurface environments. Science (2003) 3.68
Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone. N Engl J Med (1993) 3.62
A case-management system for coronary risk factor modification after acute myocardial infarction. Ann Intern Med (1994) 3.61
Standardized percentile curves of body-mass index for children and adolescents. Am J Dis Child (1991) 3.29
The role of influenza A virus hemagglutinin residues 226 and 228 in receptor specificity and host range restriction. J Virol (1998) 3.25
Criterion validity of the NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3). J Am Acad Child Adolesc Psychiatry (1996) 3.24
A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med (1996) 3.20
Cost-effectiveness of practice-initiated quality improvement for depression: results of a randomized controlled trial. JAMA (2001) 3.08
Does television viewing increase obesity and reduce physical activity? Cross-sectional and longitudinal analyses among adolescent girls. Pediatrics (1993) 3.04
Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks. J Virol (1997) 3.00
The consequences in young adulthood of adolescent drug involvement. An overview. Arch Gen Psychiatry (1986) 2.93
Comparative safety and effectiveness of sitagliptin in patients with type 2 diabetes: retrospective population based cohort study. BMJ (2013) 2.92
Analog classroom assessment of Adderall in children with ADHD. J Am Acad Child Adolesc Psychiatry (1998) 2.86
Normative data on revised Conners Parent and Teacher Rating Scales. J Abnorm Child Psychol (1978) 2.82
National survey of problems and competencies among four- to sixteen-year-olds: parents' reports for normative and clinical samples. Monogr Soc Res Child Dev (1991) 2.75
Cause for concern? Br Dent J (2004) 2.74
ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry (2001) 2.74
Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Arch Gen Psychiatry (1997) 2.70
Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci U S A (1995) 2.70
The Diagnostic Interview Schedule for Children-Revised Version (DISC-R): I. Preparation, field testing, interrater reliability, and acceptability. J Am Acad Child Adolesc Psychiatry (1993) 2.69
SSRI-induced mania. J Am Acad Child Adolesc Psychiatry (1996) 2.69
Cell cycle tyrosine phosphorylation of p34cdc2 and a microtubule-associated protein kinase homolog in Xenopus oocytes and eggs. Mol Cell Biol (1991) 2.69
The composition and physicochemical properties of hyaluronic acids prepared from ox synovial fluid and from a case of mesothelioma. Biochem J (1965) 2.68
A multicenter comparison of cognitive-behavioral therapy and interpersonal psychotherapy for bulimia nervosa. Arch Gen Psychiatry (2000) 2.67
Genetic relationship of populations in China. Proc Natl Acad Sci U S A (1998) 2.65
Oxidative damage and protection of the RPE. Prog Retin Eye Res (2000) 2.65
Monoallelic expression of the interleukin-2 locus. Science (1998) 2.58
Group- vs home-based exercise training in healthy older men and women. A community-based clinical trial. JAMA (1991) 2.58
A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis. N Engl J Med (1992) 2.57
Partial purification and characterization of the maturation-promoting factor from eggs of Xenopus laevis. Dev Biol (1980) 2.53
Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis. Lancet (1977) 2.53
Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch Gen Psychiatry (2001) 2.51
Lithium phthalocyanine: a probe for electron paramagnetic resonance oximetry in viable biological systems. Proc Natl Acad Sci U S A (1993) 2.50
Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry (1996) 2.49
Quality of diabetes care in the UK: comparison of published quality-of-care reports with results of the Quality and Outcomes Framework for Diabetes. Diabet Med (2007) 2.48
Death of Diana, Princess of Wales. Her death and funeral rate as traumatic stressors. BMJ (1997) 2.47
Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells. Proc Natl Acad Sci U S A (1989) 2.46
Age and gender differences in oppositional behavior and conduct problems: a cross-sectional household study of middle childhood and adolescence. J Abnorm Psychol (2000) 2.45
The NIMH Methods for the Epidemiology of Child and Adolescent Mental Disorders (MECA) Study: background and methodology. J Am Acad Child Adolesc Psychiatry (1996) 2.43
A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess (2005) 2.42
Establishment of the dorso-ventral axis in Xenopus embryos is presaged by early asymmetries in beta-catenin that are modulated by the Wnt signaling pathway. J Cell Biol (1997) 2.42
Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): an empirical analysis in the MTA study. J Abnorm Child Psychol (2000) 2.36